Alan Horsager is currently the President & CEO of Episona, a molecular diagnostics company focused inmen’s reproductive health. Most recently, he was a Founder and Chief Science Officer of Eos Neuroscience, a company that continues to engineer optogenetic gene therapies for blindness and chronic pain. Prior to Eos and while at the University of Southern California, he worked closely with SecondSight Medical Products to produce the first ever treatment of neurological blindness, a medical device that is now approved by the FDA for the treatment of retinitis pigmentosa. Before joining USC, he was a Project Manager and Researcher at VivoMetrics, a medical device startup that developed a wearable ambulatory monitoring system that continuously collected cardiopulmonary data. Alan received his B.A.in Psychology for the University of Washington and his Ph.D. in Neuroscience from the University ofSouthern California where he currently is a visiting Research Assistant Professor in the Department of Ophthalmology. He has numerous scientific publications and issued patents, and has received several career awards including the Burroughs Wellcome Fund CASI award.